India Innovation Series (IIS-1) – CAR-T Cell Therapy Indian Innovations
A scientific webinar focused on CAR-T Cell Therapy innovations in India, highlighting advances in immune engineering and next-generation cancer treatment strategies.
100+
Delegates
20+
Global Speakers
1
Days of Learning
Event Overview
India Innovation Series (IIS-1) is an academic medical webinar dedicated to the latest advancements in CAR-T Cell Therapy and immune engineering innovations in India. The program features leading experts in hematology, oncology, and cellular therapy discussing the safety, feasibility, challenges, and indigenous development of CAR-T therapies. Organized in collaboration with healthcare and biotechnology partners, the webinar includes expert talks, scientific presentations, and panel discussions focused on modern immunotherapy approaches in cancer treatment.
Key Focus Areas
CAR-T Cell Therapy
Immunotherapy
Hemato-Oncology
Immune Engineering
Cellular Therapy
Cancer Research
Oncology Innovation
Medical Education
Aim & Objective
To provide updated scientific knowledge on CAR-T Cell Therapy innovations and promote understanding of emerging immunotherapy strategies in India.
Program Procedure
Participants attend the webinar online through the official virtual platform. The program includes presentations, expert lectures, and interactive panel discussions.
Conclusions & Impact
The webinar aims to encourage innovation in cancer immunotherapy, improve awareness about CAR-T cell therapy, and strengthen collaboration among oncology and hematology professionals.